nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—ALB—multiple sclerosis	0.549	1	CbGaD
Sucralfate—FGA—brainstem—multiple sclerosis	0.0098	0.0943	CbGeAlD
Sucralfate—PGA5—nervous system—multiple sclerosis	0.00883	0.0849	CbGeAlD
Sucralfate—PGA5—central nervous system—multiple sclerosis	0.0085	0.0818	CbGeAlD
Sucralfate—EGF—brainstem—multiple sclerosis	0.00716	0.0689	CbGeAlD
Sucralfate—EGF—retina—multiple sclerosis	0.00691	0.0664	CbGeAlD
Sucralfate—PGA5—brain—multiple sclerosis	0.00675	0.0649	CbGeAlD
Sucralfate—FGA—nervous system—multiple sclerosis	0.00514	0.0494	CbGeAlD
Sucralfate—FGA—central nervous system—multiple sclerosis	0.00495	0.0476	CbGeAlD
Sucralfate—FGA—cerebellum—multiple sclerosis	0.00483	0.0465	CbGeAlD
Sucralfate—EGF—spinal cord—multiple sclerosis	0.00445	0.0428	CbGeAlD
Sucralfate—FGF2—medulla oblongata—multiple sclerosis	0.00441	0.0424	CbGeAlD
Sucralfate—FGF2—midbrain—multiple sclerosis	0.00403	0.0387	CbGeAlD
Sucralfate—FGF2—spinal cord—multiple sclerosis	0.00393	0.0378	CbGeAlD
Sucralfate—FGA—brain—multiple sclerosis	0.00393	0.0378	CbGeAlD
Sucralfate—EGF—nervous system—multiple sclerosis	0.00375	0.0361	CbGeAlD
Sucralfate—EGF—central nervous system—multiple sclerosis	0.00361	0.0347	CbGeAlD
Sucralfate—EGF—cerebellum—multiple sclerosis	0.00353	0.0339	CbGeAlD
Sucralfate—FGF2—cerebellum—multiple sclerosis	0.00311	0.03	CbGeAlD
Sucralfate—EGF—brain—multiple sclerosis	0.00287	0.0276	CbGeAlD
Sucralfate—FGF2—brain—multiple sclerosis	0.00253	0.0243	CbGeAlD
Sucralfate—ALB—brain—multiple sclerosis	0.000991	0.00953	CbGeAlD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—MAPK1—multiple sclerosis	8.61e-05	0.000248	CbGpPWpGaD
Sucralfate—EGF—Immune System—CD8A—multiple sclerosis	8.6e-05	0.000248	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—IL6—multiple sclerosis	8.57e-05	0.000247	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—SPP1—multiple sclerosis	8.55e-05	0.000247	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	8.49e-05	0.000245	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—CD4—multiple sclerosis	8.48e-05	0.000245	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—GPR65—multiple sclerosis	8.47e-05	0.000244	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—IL6—multiple sclerosis	8.44e-05	0.000243	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PTGER4—multiple sclerosis	8.4e-05	0.000242	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—SPP1—multiple sclerosis	8.38e-05	0.000242	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—SPP1—multiple sclerosis	8.38e-05	0.000242	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CCR5—multiple sclerosis	8.32e-05	0.00024	CbGpPWpGaD
Sucralfate—EGF—Immune System—HLA-B—multiple sclerosis	8.27e-05	0.000239	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PGR—multiple sclerosis	8.27e-05	0.000239	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—IL2RA—multiple sclerosis	8.2e-05	0.000236	CbGpPWpGaD
Sucralfate—EGF—Disease—CD86—multiple sclerosis	8.19e-05	0.000236	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CCR5—multiple sclerosis	8.15e-05	0.000235	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CCR5—multiple sclerosis	8.15e-05	0.000235	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—CD4—multiple sclerosis	8.14e-05	0.000235	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	8.14e-05	0.000235	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CXCR3—multiple sclerosis	8.11e-05	0.000234	CbGpPWpGaD
Sucralfate—FGA—Disease—TYK2—multiple sclerosis	8.08e-05	0.000233	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—IL6—multiple sclerosis	8.06e-05	0.000232	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—IL6—multiple sclerosis	8.04e-05	0.000232	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CD28—multiple sclerosis	8.04e-05	0.000232	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—IL2RA—multiple sclerosis	8.03e-05	0.000232	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—IL2RA—multiple sclerosis	8.03e-05	0.000232	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—IL6—multiple sclerosis	8.02e-05	0.000231	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—HLA-A—multiple sclerosis	8e-05	0.000231	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—IL6—multiple sclerosis	7.98e-05	0.00023	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—IL6—multiple sclerosis	7.94e-05	0.000229	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CCR2—multiple sclerosis	7.89e-05	0.000228	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CD28—multiple sclerosis	7.87e-05	0.000227	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL2RA—multiple sclerosis	7.75e-05	0.000224	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CXCL13—multiple sclerosis	7.75e-05	0.000223	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCR1—multiple sclerosis	7.75e-05	0.000223	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PTPRC—multiple sclerosis	7.73e-05	0.000223	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CCR2—multiple sclerosis	7.73e-05	0.000223	CbGpPWpGaD
Sucralfate—EGF—Immune System—HLA-A—multiple sclerosis	7.67e-05	0.000221	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—TLR4—multiple sclerosis	7.62e-05	0.00022	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—APOE—multiple sclerosis	7.57e-05	0.000218	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—IL6—multiple sclerosis	7.47e-05	0.000215	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—IL6—multiple sclerosis	7.47e-05	0.000215	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—IL6—multiple sclerosis	7.47e-05	0.000215	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HLA-DPB1—multiple sclerosis	7.47e-05	0.000215	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TNF—multiple sclerosis	7.43e-05	0.000214	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—APOE—multiple sclerosis	7.41e-05	0.000214	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—APOE—multiple sclerosis	7.41e-05	0.000214	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—IL6—multiple sclerosis	7.4e-05	0.000213	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	7.37e-05	0.000213	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—IL6—multiple sclerosis	7.34e-05	0.000212	CbGpPWpGaD
Sucralfate—FGA—Disease—CD4—multiple sclerosis	7.31e-05	0.000211	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—HLA-DRB1—multiple sclerosis	7.31e-05	0.000211	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—IL6—multiple sclerosis	7.31e-05	0.000211	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—STAT3—multiple sclerosis	7.29e-05	0.00021	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CNR1—multiple sclerosis	7.28e-05	0.00021	CbGpPWpGaD
Sucralfate—FGF2—Disease—CD28—multiple sclerosis	7.26e-05	0.000209	CbGpPWpGaD
Sucralfate—EGF—Disease—CCR5—multiple sclerosis	7.26e-05	0.000209	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—TGFB1—multiple sclerosis	7.2e-05	0.000208	CbGpPWpGaD
Sucralfate—FGF2—Immune System—ITGA4—multiple sclerosis	7.18e-05	0.000207	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CD40—multiple sclerosis	7.18e-05	0.000207	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IFNB1—multiple sclerosis	7.13e-05	0.000206	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CTLA4—multiple sclerosis	7.08e-05	0.000204	CbGpPWpGaD
Sucralfate—EGF—Disease—HLA-A—multiple sclerosis	7.08e-05	0.000204	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CD80—multiple sclerosis	7.03e-05	0.000203	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—ICAM1—multiple sclerosis	7.01e-05	0.000202	CbGpPWpGaD
Sucralfate—EGF—Immune System—TLR4—multiple sclerosis	7.01e-05	0.000202	CbGpPWpGaD
Sucralfate—EGF—Immune System—HLA-DRB1—multiple sclerosis	7e-05	0.000202	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SRM—multiple sclerosis	6.92e-05	0.0002	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—SELE—multiple sclerosis	6.91e-05	0.000199	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CD80—multiple sclerosis	6.84e-05	0.000197	CbGpPWpGaD
Sucralfate—ALB—Platelet degranulation—TGFB1—multiple sclerosis	6.82e-05	0.000197	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—TGFB1—multiple sclerosis	6.76e-05	0.000195	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CD80—multiple sclerosis	6.75e-05	0.000195	CbGpPWpGaD
Sucralfate—EGF—Immune System—ICAM1—multiple sclerosis	6.72e-05	0.000194	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—TYK2—multiple sclerosis	6.72e-05	0.000194	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.71e-05	0.000193	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CD80—multiple sclerosis	6.7e-05	0.000193	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CD80—multiple sclerosis	6.7e-05	0.000193	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—MAPK1—multiple sclerosis	6.63e-05	0.000191	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—MAPK1—multiple sclerosis	6.62e-05	0.000191	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	6.62e-05	0.000191	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—IL6—multiple sclerosis	6.62e-05	0.000191	CbGpPWpGaD
Sucralfate—EGF—Disease—APOE—multiple sclerosis	6.61e-05	0.000191	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CXCL10—multiple sclerosis	6.56e-05	0.000189	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—POMC—multiple sclerosis	6.5e-05	0.000187	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	6.5e-05	0.000187	CbGpPWpGaD
Sucralfate—EGF—Immune System—CD80—multiple sclerosis	6.47e-05	0.000187	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—POMC—multiple sclerosis	6.37e-05	0.000184	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—POMC—multiple sclerosis	6.37e-05	0.000184	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CCL2—multiple sclerosis	6.36e-05	0.000183	CbGpPWpGaD
Sucralfate—FGF2—Immune System—VCAM1—multiple sclerosis	6.25e-05	0.00018	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HLA-DQA1—multiple sclerosis	6.23e-05	0.00018	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CCL2—multiple sclerosis	6.23e-05	0.00018	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CCL2—multiple sclerosis	6.23e-05	0.00018	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—IL6—multiple sclerosis	6e-05	0.000173	CbGpPWpGaD
Sucralfate—EGF—Disease—CD80—multiple sclerosis	5.97e-05	0.000172	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—MAPK1—multiple sclerosis	5.97e-05	0.000172	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—TYK2—multiple sclerosis	5.94e-05	0.000171	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.93e-05	0.000171	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	5.9e-05	0.00017	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HLA-DQB1—multiple sclerosis	5.83e-05	0.000168	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TYK2—multiple sclerosis	5.78e-05	0.000167	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CD86—multiple sclerosis	5.73e-05	0.000165	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TYK2—multiple sclerosis	5.66e-05	0.000163	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TYK2—multiple sclerosis	5.66e-05	0.000163	CbGpPWpGaD
Sucralfate—FGA—Disease—STAT3—multiple sclerosis	5.66e-05	0.000163	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CCL5—multiple sclerosis	5.65e-05	0.000163	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CD86—multiple sclerosis	5.61e-05	0.000162	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCL3—multiple sclerosis	5.52e-05	0.000159	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CD40LG—multiple sclerosis	5.5e-05	0.000159	CbGpPWpGaD
Sucralfate—EGF—Immune System—TYK2—multiple sclerosis	5.46e-05	0.000157	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CD8A—multiple sclerosis	5.44e-05	0.000157	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CD4—multiple sclerosis	5.37e-05	0.000155	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PTGER4—multiple sclerosis	5.32e-05	0.000153	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—MMP9—multiple sclerosis	5.29e-05	0.000153	CbGpPWpGaD
Sucralfate—FGA—Disease—MYC—multiple sclerosis	5.26e-05	0.000152	CbGpPWpGaD
Sucralfate—FGA—Disease—TGFB1—multiple sclerosis	5.24e-05	0.000151	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HLA-B—multiple sclerosis	5.24e-05	0.000151	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PGR—multiple sclerosis	5.24e-05	0.000151	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—SPP1—multiple sclerosis	5.23e-05	0.000151	CbGpPWpGaD
Sucralfate—FGF2—Disease—CD86—multiple sclerosis	5.18e-05	0.000149	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CD4—multiple sclerosis	5.15e-05	0.000149	CbGpPWpGaD
Sucralfate—FGA—Disease—MAPK1—multiple sclerosis	5.14e-05	0.000148	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CXCR3—multiple sclerosis	5.13e-05	0.000148	CbGpPWpGaD
Sucralfate—EGF—Immune System—IFNG—multiple sclerosis	5.11e-05	0.000147	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—IL6—multiple sclerosis	5.09e-05	0.000147	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CD28—multiple sclerosis	5.09e-05	0.000147	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CCR5—multiple sclerosis	5.09e-05	0.000147	CbGpPWpGaD
Sucralfate—EGF—Disease—TYK2—multiple sclerosis	5.04e-05	0.000145	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IL2RA—multiple sclerosis	5.01e-05	0.000145	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCR2—multiple sclerosis	4.99e-05	0.000144	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—ITGA4—multiple sclerosis	4.99e-05	0.000144	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—IFNB1—multiple sclerosis	4.96e-05	0.000143	CbGpPWpGaD
Sucralfate—EGF—Immune System—CD4—multiple sclerosis	4.94e-05	0.000142	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL2RA—multiple sclerosis	4.91e-05	0.000141	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CYP27B1—multiple sclerosis	4.88e-05	0.000141	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CYP24A1—multiple sclerosis	4.88e-05	0.000141	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HLA-A—multiple sclerosis	4.85e-05	0.00014	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—IL2—multiple sclerosis	4.81e-05	0.000139	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.77e-05	0.000137	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	4.76e-05	0.000137	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—IL2—multiple sclerosis	4.71e-05	0.000136	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—IL2—multiple sclerosis	4.71e-05	0.000136	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—STAT3—multiple sclerosis	4.71e-05	0.000136	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—APOE—multiple sclerosis	4.63e-05	0.000133	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CNR1—multiple sclerosis	4.61e-05	0.000133	CbGpPWpGaD
Sucralfate—FGF2—Disease—CCR5—multiple sclerosis	4.6e-05	0.000133	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—IL6—multiple sclerosis	4.59e-05	0.000132	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL1B—multiple sclerosis	4.56e-05	0.000132	CbGpPWpGaD
Sucralfate—EGF—Disease—CD4—multiple sclerosis	4.56e-05	0.000132	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—MMP9—multiple sclerosis	4.55e-05	0.000131	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL2—multiple sclerosis	4.55e-05	0.000131	CbGpPWpGaD
Sucralfate—FGF2—Disease—HLA-A—multiple sclerosis	4.48e-05	0.000129	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GPC5—multiple sclerosis	4.46e-05	0.000129	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—MMP9—multiple sclerosis	4.46e-05	0.000128	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—MMP9—multiple sclerosis	4.46e-05	0.000128	CbGpPWpGaD
Sucralfate—FGF2—Immune System—TLR4—multiple sclerosis	4.44e-05	0.000128	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HLA-DRB1—multiple sclerosis	4.43e-05	0.000128	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—TGFB1—multiple sclerosis	4.36e-05	0.000126	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—MAPK1—multiple sclerosis	4.28e-05	0.000123	CbGpPWpGaD
Sucralfate—FGF2—Immune System—ICAM1—multiple sclerosis	4.25e-05	0.000123	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CD80—multiple sclerosis	4.18e-05	0.000121	CbGpPWpGaD
Sucralfate—FGF2—Disease—APOE—multiple sclerosis	4.18e-05	0.000121	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CXCL10—multiple sclerosis	4.15e-05	0.00012	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CD80—multiple sclerosis	4.09e-05	0.000118	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—TNF—multiple sclerosis	4.07e-05	0.000117	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—STAT3—multiple sclerosis	4.04e-05	0.000117	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—POMC—multiple sclerosis	3.97e-05	0.000115	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—STAT3—multiple sclerosis	3.96e-05	0.000114	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—STAT3—multiple sclerosis	3.96e-05	0.000114	CbGpPWpGaD
Sucralfate—FGA—Disease—IL6—multiple sclerosis	3.95e-05	0.000114	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CCL2—multiple sclerosis	3.89e-05	0.000112	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	3.88e-05	0.000112	CbGpPWpGaD
Sucralfate—EGF—Immune System—STAT3—multiple sclerosis	3.82e-05	0.00011	CbGpPWpGaD
Sucralfate—FGF2—Disease—CD80—multiple sclerosis	3.78e-05	0.000109	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—MAPK1—multiple sclerosis	3.78e-05	0.000109	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—MYC—multiple sclerosis	3.76e-05	0.000108	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TGFB1—multiple sclerosis	3.75e-05	0.000108	CbGpPWpGaD
Sucralfate—ALB—Metabolism—RRM1—multiple sclerosis	3.7e-05	0.000107	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—MYC—multiple sclerosis	3.68e-05	0.000106	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—MYC—multiple sclerosis	3.68e-05	0.000106	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—MAPK1—multiple sclerosis	3.68e-05	0.000106	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TGFB1—multiple sclerosis	3.67e-05	0.000106	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TGFB1—multiple sclerosis	3.67e-05	0.000106	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CD86—multiple sclerosis	3.63e-05	0.000105	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—MAPK1—multiple sclerosis	3.6e-05	0.000104	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—MAPK1—multiple sclerosis	3.6e-05	0.000104	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCL5—multiple sclerosis	3.57e-05	0.000103	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TYK2—multiple sclerosis	3.53e-05	0.000102	CbGpPWpGaD
Sucralfate—EGF—Disease—STAT3—multiple sclerosis	3.53e-05	0.000102	CbGpPWpGaD
Sucralfate—EGF—Immune System—MAPK1—multiple sclerosis	3.48e-05	0.0001	CbGpPWpGaD
Sucralfate—FGF2—Immune System—TYK2—multiple sclerosis	3.46e-05	9.97e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—IL2RA—multiple sclerosis	3.41e-05	9.84e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SPP1—multiple sclerosis	3.31e-05	9.54e-05	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—IL6—multiple sclerosis	3.29e-05	9.48e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—MYC—multiple sclerosis	3.28e-05	9.46e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—TGFB1—multiple sclerosis	3.27e-05	9.44e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IFNG—multiple sclerosis	3.24e-05	9.33e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCR5—multiple sclerosis	3.22e-05	9.28e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—MAPK1—multiple sclerosis	3.21e-05	9.26e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—TYK2—multiple sclerosis	3.19e-05	9.2e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IL2RA—multiple sclerosis	3.17e-05	9.15e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CD4—multiple sclerosis	3.13e-05	9.01e-05	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	3.03e-05	8.73e-05	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	2.97e-05	8.56e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IL2—multiple sclerosis	2.94e-05	8.47e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—APOE—multiple sclerosis	2.93e-05	8.44e-05	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—IL6—multiple sclerosis	2.9e-05	8.37e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL1B—multiple sclerosis	2.89e-05	8.32e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—CD4—multiple sclerosis	2.89e-05	8.32e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL2—multiple sclerosis	2.88e-05	8.29e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.87e-05	8.27e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—IL6—multiple sclerosis	2.82e-05	8.15e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MMP9—multiple sclerosis	2.78e-05	8.02e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—IL6—multiple sclerosis	2.77e-05	7.98e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—IL6—multiple sclerosis	2.77e-05	7.98e-05	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL6—multiple sclerosis	2.67e-05	7.7e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CD80—multiple sclerosis	2.65e-05	7.63e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—POMC—multiple sclerosis	2.52e-05	7.25e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—STAT3—multiple sclerosis	2.47e-05	7.13e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—IL6—multiple sclerosis	2.47e-05	7.11e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.46e-05	7.1e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCL2—multiple sclerosis	2.46e-05	7.1e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—STAT3—multiple sclerosis	2.42e-05	6.98e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MYC—multiple sclerosis	2.3e-05	6.63e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TGFB1—multiple sclerosis	2.29e-05	6.61e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MAPK1—multiple sclerosis	2.25e-05	6.48e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TYK2—multiple sclerosis	2.23e-05	6.44e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—STAT3—multiple sclerosis	2.23e-05	6.44e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—MAPK1—multiple sclerosis	2.2e-05	6.34e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—BCHE—multiple sclerosis	2.12e-05	6.12e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—MYC—multiple sclerosis	2.08e-05	5.99e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—TGFB1—multiple sclerosis	2.07e-05	5.97e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—MAPK1—multiple sclerosis	2.03e-05	5.86e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—IL2—multiple sclerosis	2e-05	5.77e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IL2—multiple sclerosis	1.86e-05	5.36e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MMP9—multiple sclerosis	1.76e-05	5.07e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IL6—multiple sclerosis	1.73e-05	4.98e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL6—multiple sclerosis	1.69e-05	4.87e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—STAT3—multiple sclerosis	1.56e-05	4.51e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—IL6—multiple sclerosis	1.56e-05	4.5e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TGFB1—multiple sclerosis	1.56e-05	4.5e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—MAPK1—multiple sclerosis	1.53e-05	4.41e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MYC—multiple sclerosis	1.45e-05	4.19e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TGFB1—multiple sclerosis	1.45e-05	4.18e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MAPK1—multiple sclerosis	1.42e-05	4.1e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—APOE—multiple sclerosis	1.28e-05	3.68e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—POMC—multiple sclerosis	1.1e-05	3.16e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IL6—multiple sclerosis	1.09e-05	3.15e-05	CbGpPWpGaD
